Cargando…
Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma
The purpose is to report a case of immunogammopathy maculopathy and hyperviscosity retinopathy as the presenting feature of new-onset multiple myeloma (MM) in an otherwise healthy man. A 50-years-old man presented with painless visual changes in both eyes for 2 months. Ocular examination revealed bi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299375/ https://www.ncbi.nlm.nih.gov/pubmed/34326757 http://dx.doi.org/10.1159/000514695 |
_version_ | 1783726257294278656 |
---|---|
author | Ferreira Santos da Cruz, Natasha Milhomens Filho, José Arthur Pinto Ferraro, Desirée Mayara Nery Polizelli, Murilo Ubukata de Moraes Ambrogini, Nilva Simeren Bueno |
author_facet | Ferreira Santos da Cruz, Natasha Milhomens Filho, José Arthur Pinto Ferraro, Desirée Mayara Nery Polizelli, Murilo Ubukata de Moraes Ambrogini, Nilva Simeren Bueno |
author_sort | Ferreira Santos da Cruz, Natasha |
collection | PubMed |
description | The purpose is to report a case of immunogammopathy maculopathy and hyperviscosity retinopathy as the presenting feature of new-onset multiple myeloma (MM) in an otherwise healthy man. A 50-years-old man presented with painless visual changes in both eyes for 2 months. Ocular examination revealed bilateral CRVO-like associated with macular edema (ME) and an inferior serous detachment. Hematologic investigation revealed an increased percentage of plasma cells in the bone marrow, reaching the diagnosis of MM IgM/kappa. Clinical support and chemotherapy effectively improved ocular alterations, despite the residual ME. Injection of triamcinolone was carried out, without any response. Bilateral vision reduction with hyperviscosity syndrome-related retinopathy and immunogammopathy maculopathy was the first manifestation of an underlying systemic and potentially fatal disease. This case highlights the need for diligent and thorough investigations for less common systemic conditions associated with retinal vein occlusions. |
format | Online Article Text |
id | pubmed-8299375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-82993752021-07-28 Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma Ferreira Santos da Cruz, Natasha Milhomens Filho, José Arthur Pinto Ferraro, Desirée Mayara Nery Polizelli, Murilo Ubukata de Moraes Ambrogini, Nilva Simeren Bueno Case Rep Ophthalmol Case Report The purpose is to report a case of immunogammopathy maculopathy and hyperviscosity retinopathy as the presenting feature of new-onset multiple myeloma (MM) in an otherwise healthy man. A 50-years-old man presented with painless visual changes in both eyes for 2 months. Ocular examination revealed bilateral CRVO-like associated with macular edema (ME) and an inferior serous detachment. Hematologic investigation revealed an increased percentage of plasma cells in the bone marrow, reaching the diagnosis of MM IgM/kappa. Clinical support and chemotherapy effectively improved ocular alterations, despite the residual ME. Injection of triamcinolone was carried out, without any response. Bilateral vision reduction with hyperviscosity syndrome-related retinopathy and immunogammopathy maculopathy was the first manifestation of an underlying systemic and potentially fatal disease. This case highlights the need for diligent and thorough investigations for less common systemic conditions associated with retinal vein occlusions. S. Karger AG 2021-07-01 /pmc/articles/PMC8299375/ /pubmed/34326757 http://dx.doi.org/10.1159/000514695 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Case Report Ferreira Santos da Cruz, Natasha Milhomens Filho, José Arthur Pinto Ferraro, Desirée Mayara Nery Polizelli, Murilo Ubukata de Moraes Ambrogini, Nilva Simeren Bueno Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma |
title | Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma |
title_full | Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma |
title_fullStr | Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma |
title_full_unstemmed | Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma |
title_short | Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma |
title_sort | hyperviscosity retinopathy and immunogammopathy maculopahy as new onset of multiple myeloma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299375/ https://www.ncbi.nlm.nih.gov/pubmed/34326757 http://dx.doi.org/10.1159/000514695 |
work_keys_str_mv | AT ferreirasantosdacruznatasha hyperviscosityretinopathyandimmunogammopathymaculopahyasnewonsetofmultiplemyeloma AT milhomensfilhojosearthurpinto hyperviscosityretinopathyandimmunogammopathymaculopahyasnewonsetofmultiplemyeloma AT ferrarodesireemayaranery hyperviscosityretinopathyandimmunogammopathymaculopahyasnewonsetofmultiplemyeloma AT polizellimuriloubukata hyperviscosityretinopathyandimmunogammopathymaculopahyasnewonsetofmultiplemyeloma AT demoraesambrogininilvasimerenbueno hyperviscosityretinopathyandimmunogammopathymaculopahyasnewonsetofmultiplemyeloma |